Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Case series:FNC
Sponsors
Zhongnan Hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Aged >=18 years old inpatient; (2) novel coronavirus nucleic acid positive was detected by real-time fluorescent RT-PCR in throat swabs; (3) The clinical types were common type or severe type; (4) Informed consent has been signed.
Exclusion criteria
Exclusion criteria: (1) It is known or suspected that it is allergic to the components of azvudine tablets; (2) Light or severe patients; (3) Patients with dysabsorption syndrome, or any other condition that affects gastrointestinal absorption, or who are unable to take drugs orally; (4) Severe liver diseases (such as child Pugh score>=C, TBIL>=2 times the upper limit of normal value, ALT/AST>=5 ULN, or HBsAg positive; (5) Patients with severe renal insufficiency (eGFR<=30ml/min/1.73m2) or undergoing continuous renal replacement therapy, hemodialysis and peritoneal dialysis; (6) Women during pregnancy and lactation or having family planning during the trial period / within 6 months of the end of the trial; (7) Other factors that are not suitable for entering the trial (According to the judgment of the researcher).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Time to Clinical Recovery; | — |
Primary
| Measure | Time frame |
|---|---|
| The novel coronavirus nucleic acid negative rate; | — |
Countries
China
Contacts
Public ContactCheng Zhenshun
Zhongnan Hospital of Wuhan University
Outcome results
None listed